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Healthy ageing and the prediction of
mortality and incidence dependence in
low- and middle- income countries: a 10/66
population-based cohort study
Christina Daskalopoulou1* , Martin Prince1, Artemis Koukounari2, Josep Maria Haro3,
Demosthenes B. Panagiotakos4 and A. Matthew Prina1
Abstract
Background: In the absence of a consensus on definition and measurement of healthy ageing, we created a
healthy ageing index tallying with the functional ability framework provided by the World Health Organization. To
create this index, we employed items of functional ability and intrinsic capacity. The current study aims to establish
the predictive validity and discrimination properties of this healthy ageing index in settings in Latin American, part
of the 10/66 cohort.
Methods: Population-based cohort studies including 12,865 people ≥65 years old in catchment areas of Cuba,
Dominican Republic, Venezuela, Mexico and Peru. We employed latent variable modelling to estimate the healthy
ageing scores of each participant. We grouped participants according to the quintiles of the healthy ageing score
distribution. Cox’s proportional hazard models for mortality and sub-hazard (competing risks) models for incident
dependence (i.e. needing care) were calculated per area after a median of 3.9 years and 3.7 years, respectively.
Results were pooled together via fixed-effects meta-analysis. Our findings were compared with those obtained from
self-rated health.
Results: Participants with lowest levels, compared to participants with highest level of healthy ageing, had
increased risk of mortality and incident dependence, even after adjusting for sociodemographic and health
conditions (HR: 3.25, 95%CI: 2.63–4.02; sub-HR: 5.21, 95%CI: 4.02–6.75). Healthy ageing scores compared to self-rated
health had higher population attributable fractions (PAFs) for mortality (43.6% vs 19.3%) and incident dependence
(58.6% vs 17.0%), and better discriminative power (Harrell’s c-statistic: mortality 0.74 vs 0.72; incident dependence
0.76 vs 0.70).
Conclusion: These results provide evidence that our healthy ageing index could be a valuable tool for prevention
strategies as it demonstrated predictive and discriminative properties. Further research in other cultural settings will
assist moving from a theoretical conceptualisation of healthy ageing to a more practical one.
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Background
The number of people aged 60 years old and over will
grow by 56% between 2015 and 2030; Latin American
countries are expected to experience the fastest increase
[1]. However, an increased life expectancy does not
entail that these additional years will be spent in good
health [2]. Old age has been associated with an increasing
demand for care, services and expertise to treat or prevent
the onset of non-communicable and chronic diseases [1].
In addition, the association between chronological age and
health status is characterised by variability as there are dif-
ferences in the health and functional status of older people
[3]. People age with great diversity meaning that they
could reach old age by remaining robust, dependent or in
between [4]. Therefore, in this heterogeneous context,
having a tool to identify those who are at greater risk of
mortality or needing care will contribute to the establish-
ment of effective policy interventions.
Research in healthy ageing, until recently, has been com-
plicated by the lack of a consensus around its definition or
measurement [5, 6]. During the last few years, a growing
body of research has been shifted towards the creation of a
healthy/successful ageing index and how the latter can as-
sist in the prediction of health-related outcomes or mortal-
ity [7–9]. Indexes have been created either by using solely
clinical biomarkers, [8] or a mixture of physiological, and
psychosocial components [7, 9]. In response to the latest re-
port World Health Organization (WHO) report [4] and to
the “Global strategy and action plan on ageing and health
(2016-2020)” [10], we created a healthy ageing index
conceptualised upon the framework of functional ability
(BMRM-D-18-00329). This index was developed in a popu-
lation cohort of older adults from Latin American countries
(Cuba, Dominican Republic, Mexico, Peru, Puerto Rico,
Venezuela), part of the baseline survey of the 10/66 cohort.
The index was checked for various psychometric properties,
including measurement invariance among countries and
gender, and concurrent convergent validity with self-rated
health (BMRM-D-18-00329). In the current study, we
aimed to investigate the predictive validity and the discrim-
ination properties of this index on mortality and incident
dependence risk in the follow-up wave of the 10/66 cohort.
We also compare our findings with those of a measure of
self-rated health, as evidence suggested that the latter has
strong associations with mortality [11, 12] and with other
adverse health outcomes [13, 14].
Methods
Design and setting of the study
The 10/66 Dementia Research Group (10/66 DRG) is a
multicentre population-based study of ageing and de-
mentia in low-and-middle income countries. Residents
aged 65 years old and over were interviewed in the base-
line surveys which took place between 2003 and 2010;
follow-up surveys followed 3 to 5 years later. In cases
where the participant could not be traced, information
about vital status and current residence was sought from
friends or family members, whose contract details had
been recorded at baseline. In cases where participant’s
capacity to provide reliable information was in doubt,
the information was corroborated by an informant. The
current secondary analyses included data from catchment
areas in Latin America (Cuba, Dominican Republic, Peru,
Venezuela, Mexico and Puerto Rico). Local ethical com-
mittees and the ethical committee of the Institute of
Psychiatry of King’s College London approved the studies
[15, 16]. In this study, we will describe aspects directly
relevant to the presented analyses.
Healthy ageing index
The healthy ageing index comprised 26 health question-
indicators which were either self-reported or provided
by key informants from the following questionnaires and
questions.
 difficulty in: household responsibilities, walking a
kilometre, washing whole body, getting dressed,
carrying out work and everyday activities (World
Health Organization Disability Assessment Schedule
2.0, WHO-DAS II)
 difficulty in: making decisions, using the toilet,
handling money, finding right word, completing
chores; change in daily activities and forgets where
he/she is (Community Screening Interview for
Dementia-Informant Scale, CSI’D’-RELSCORE)
 sleep trouble or recent change in pattern; feeling of
not coping properly with everyday routine; getting
worn out or exhausted during daytime or evening
(Geriatric Mental State Interview, GMS)
 delayed recall; long memory test; immediate
recall; verbal fluency; time orientation; praxis-fold
a piece of paper; story recall difficulty (Neurological
Examination and Community Screening Interview for
Dementia, CSI’D’)
 word list learning; time in seconds taken to walk 10
m; hearing problem; sight problem. All interview
manuals and questionnaires are available, upon
request, on the official site of the study: https://
www.alz.co.uk/1066/population_based_study_
prevalence.php.
The structural validity of this index in the 10/66 co-
hort together with psychometric properties and meas-
urement invariance tests among countries and between
men and women have been previously investigated
(BMRM-D-18-00329) [17]. Within that study, a bifactor
model emerged as the most appropriate one to concep-
tualise the latent construct of healthy ageing. More
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specifically, healthy ageing was portrayed by the general
factor within the bifactor model framework, whereas
four other subdomain factors captured additional vari-
ability. For the purposes of the following analyses, we
extracted the factor scores of the general factor using
Mplus 7.4 [18]. Finally, we transformed scores in a 0 to
100 scale with higher values indicating participants in a
better level of health.
Mortality outcome
Mortality was ascertained through screening of all re-
spondents from the baseline cohort. A verbal autopsy on
those deceased and a suitable informant interview were
completed to ascertain cause of death. Survival times
were calculated up to the date of death or were censored
to the date of follow-up survey for those participants
who were re-interviewed. For those who refused inter-
view but were found alive the median date of follow-up
interview was used to calculate censor time.
Incident dependence outcome
The need for frequent help that a healthy adult requires
has been described as dependence [19]. In the 10/66
dataset, dependence was coded in three categories: no
need for care, care some of the time and care much of
the time [20]. The interviewer assigned each participant
to these categories after asking the following questions
to an informant: who shares the home with the partici-
pant? what kind of help does the participant need inside
and outside the house? who, in the family, is available to
care for the participant? what help do you provide? do
you help to organise care and support for the partici-
pant? is there anyone else in the family more involved in
helping than you and what do they do? what about
friends and neighbours, what do they do? [21]. The same
approach was used in the baseline and follow-up sur-
veys. Participants with no need for care at baseline were
at risk for the onset of dependence in the follow-up sur-
vey; participants who were rated as needing care some
or much of the time were considered as having incident
dependence. Incident dependence for deceased partici-
pants before death was extracted after informants’
interviews. “Time-at-risk” was calculated as the total
follow-up time (until follow-up interview or death); for
those participants that had a dependence event it was as-
sumed that the onset of dependence occurred at the
midpoint of the follow-up period.
Covariates
We recorded participants’ age, sex, educational level
(none, did not complete primary, completed primary,
secondary or tertiary) and number of assets out of the
following seven: car, television, refrigerator, telephone,
mains water, mains electricity, plumbed toilet. We also
measured and adjusted our models for physical impair-
ments, stroke, dementia and depression as previous
studies showed that these are considerable contributors
of dependence and disability [22, 23]. The number of
self-reported limiting physical impairments was assessed
by the following list: arthritis or rheumatism, persistent
cough, breathlessness, difficulty breathing or asthma,
high blood pressure, heart trouble or angina, stomach or
intestine problems, faints or blackouts, paralysis, weak-
ness or loss of one leg or arm, skin disorders such as
pressure sores, leg ulcers or severe burns. We then cate-
gorised participants as having: no, one to two and three
or more illnesses. Self-reported stroke was confirmed if
the interviewer or the informant confirmed that the
former had characteristic symptoms lasting more than
24 h [24]. Depression was assessed using ICD10 (Inter-
national Classification of Diseases) criteria and dementia
was diagnosed by the cross-culturally developed, cali-
brated and validated 10/66 dementia diagnosis algorithm
[25] and the Diagnostic and Statistical Manual of Mental
Disorders (DSM-IV) manual [26]. For the needs of the
current study, we separately provide the baseline charac-
teristics for those at risk of mortality (mortality cohort)
and for those with no need for care at baseline but for
risk of incident dependence later (dependence cohort).
Statistical analyses
We performed all statistical analyses in STATA 14.1
[27]. We used cohort-specific quintiles of the healthy
ageing factors scores and used them as cut-off points to
categorise participants in five groups of healthy ageing.
Q1-quintile participants were those with the lowest level
of healthy ageing “very low level” group in the baseline
assessment, whereas Q5-quintile participants were those
of the highest level “very high level” group. Q2-quintile
participants were characterised as “low level”, Q3 as
“moderate level” and Q4 as “high level”.1 Participants
belonging to the highest level were used as reference cat-
egory for all analyses.
We examined unadjusted Kaplan-Meier curves and
employed a log-rank test to statistically test whether
there are differences in participants’ death rate among
the different healthy ageing levels. We constructed uni-
variable and multivariable Cox’s proportional hazard
(PH) models to estimate hazard ratios (HR) with 95%
CIs and associations of mortality with healthy ageing in
each country. Cox’s PH models were implemented on
no missing data (< 2.5% of the data were excluded due
to missingness in the covariates). We tested the PH
1Cut-off points of the mortality cohort: very low level: 0–47.80; low
level: 48.81–58.13; moderate level: 58.14–66.74; high level: 66.75–
78.08; very high level: 78.09–100. Cut-off points of the dependence co-
hort: very low level: 0–47.02; low level:47.03–56.53; moderate level:
56.54–65.12; high level: 65.13–73.83; very high level: 73.84–100.
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assumption by inspecting the Kaplan-Meier curves to-
gether with the Schoenfeld residuals global test [28].
We performed competing risk analysis to quantify the
risk of incident dependence by considering those partici-
pants who had the competing risk of dependence free
death. Participants, for the competing risk analysis, were
characterised as:
 Censored: survived and participated in the follow-up
survey with no need for care.
 Incident dependent: identified as dependent from
the follow-up interview or, if dead, from the
informant deceased interview.
 Having competing event: dead but with no incident
dependence as identified by the informant deceased
interview.
We modelled the effect of covariates on incident
dependence with a competing-risks regression derived
from Fine and Gray’s proportional sub-hazards model
[29]. This model (STATA stcrreg command) is based on
a cumulative incidence function, indicating the probabil-
ity of failure (i.e. onset of dependence) before a specific
time but by considering the possibility of another
competing risk (i.e. dependence-free death). In a conven-
tional Cox’s PH regression, deaths would be right-
censored, and those participants would be treated as no
more or less likely to fail from the cause of interest than
participants still at risk. However, this type of censoring
is inappropriate as after death, dependence is a non-
possible event. On the contrary, in the competing risk
regression model these participants with a competing
risk event are included in the analysis and are counted
as having no chance of failing the event of interest [28].
The sub-hazard ratios (sHR) reflect the incident depend-
ence ratio among participants who were alive at the end
of the follow-up or experienced a death event free of in-
cident dependence.
Cox’s PH models and sub-HRs models were calculated
with robust 95%CIs considering household clustering.
To combine and provide a pooled result among coun-
tries, we applied fixed-effects meta-analysis. We com-
puted Higgins I2 to estimate the proportion of between-
site variability in estimates accounted for heterogeneity,
rather than sampling error [30]. Values of 50% are usu-
ally considered as moderate heterogeneity and values of
75% are considered as high [30]. We also calculated the
population attributable fraction (PAF) with 95%CIs for
mortality and incident dependence of a dichotomised
healthy ageing exposure in the sociodemographic-
adjusted model (STATA punaf command). This com-
mand estimates the attributable fractions under two
different scenarios for the exposure variable (i.e. healthy
ageing level). PAFs represent the proportion of mortality
and incident dependence that could theoretically be
avoided if all exposure could be removed from the popu-
lation, assuming causal relationships estimated free of
confounding. Furthermore, we calculated Harrell’s c-
statistic to assess discrimination properties of the healthy
ageing index for death and dependence events (STATA
somersd command) [31]. Discrimination quantifies the
ability of a model to correctly classify participants within
the different groups of the outcome variable; a value of
0.5 indicates no predictive discrimination, whereas a
value of 1.0 indicates perfect separation [32]. We also
compared results of associated risks with regards to the
outcomes of mortality and incident dependence by using
as exposure the self-rated health of participants in the
past 30 days instead of the healthy ageing. Finally, we
performed a sensitivity analysis to examine the practical
usefulness of this healthy ageing. We investigated if our
conclusions would be affected, if a simple sum of items,
and not the healthy ageing scores of the latent variable
model, was employed.
Results
Sample study characteristics
Baseline characteristics of the mortality and dependence
free cohorts are provided per country and in aggregate
form (Tables 1 and 2). The mortality cohort comprised
12,734 individuals at baseline and for most of them
(87.9%) their vital status was available in the follow-up
wave. Mortality rates ranged from 28.4/1000 person-
years (Peru) to 62.7/1000 person-years (Dominican
Republic). The dependence cohort comprised 11,040
individuals with no need for care at baseline and more
than 80% of those had their status ascertained in the
follow-up wave. Incident dependence ranged from 33.4/
1000 person-years (Cuba) to 64.8/1000 person-years
(Dominican Republic). Venezuela and Peru had the
highest number of participants with “very high level” of
healthy ageing while Dominican Republic and Mexico
had the lowest. The mean age ranged from 72.5 in
Venezuela to 76.3 in Puerto Rico for the mortality co-
hort and from 71.5 in Venezuela to 75.2 in Puerto Rico
for the incident dependence cohort. The majority of par-
ticipants in both cohorts were females (> 63%), with six
assets (median number) and with no limiting impair-
ments or diseases (i.e. stroke, depression, dementia).
Associations between healthy ageing and mortality
Kaplan-Meier failure (death) curves per healthy ageing
level are presented in Fig. 1. Log-rank test indicated a
significant difference in time to death among the five
levels of healthy ageing (p < 0.05). The Kaplan-Meier
failure probability estimates at four years were about
0.35 for “very low level” participants, 0.18 for “low level”,
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0.12 for “moderate level” and less than 0.10 for “high
level” and “very high level”.
The Cox’s PH models for the healthy ageing index and
self-rated health are presented in Table 3. The Schoen-
feld residuals global test indicated that in most of the
cases the proportional hazard assumption was met (p-
value> 0.05). In one case where the global test indicated
a significant result (in Puerto Rico for the fully adjusted
models), further inspection of the Kaplan-Meier curves
provided support that substantial deviations of the pro-
portional hazard assumption were not detected. Table 3
shows that in the unadjusted model (model 1), “very low
level” participants had an increased risk of death com-
pared to “very high level” participants (HR = 6.89,
95%CI = 5.81–8.17) with moderate heterogeneity among
countries (I2 = 53.40%). When we adjusted this model
for sociodemographic characteristics (model 2), the asso-
ciation remained strong with less heterogeneity of effect
among areas (HR = 4.23, 95%CI = 3.48–5.13; I2 =
17.10%). After further controlling for health conditions
(model 3), associations were attenuated but remained
significant (HR = 3.25, 95%CI = 2.63–4.02; I2 = 28.70%).
Participants with “low” and “moderate” healthy ageing
levels compared with participants of “very high” level
had increased HR in all three models; effect sizes were
progressively reduced after sequentially controlling for
sociodemographic characteristics and health conditions
but remained significant. “High level” participants com-
pared to “very high level” had increased risk of mortality
in the unadjusted model which did not remain signifi-
cant once we adjusted for the other covariates. Regard-
ing self-rated health and mortality, participants with very
low and low self-rated health had an increased risk of
mortality even in the fully-adjusted models compared to
those reporting very good self-rated health (very low:
HR = 2.78, 95%CI = 2.05–3.76; low: HR = 1.68, 95%CI =
1.35–2.09). Participants of moderate and good self-rated
health had increased risk of death which did not remain
significant as we subsequently adjusted for more
covariates.
The model with only including healthy ageing scores
(i.e. unadjusted model) had better discrimination for
death compared to the model only including self-rated
health (c-statistic: 0.70 vs 0.58, p < 0.05). Healthy ageing
Table 1 Mortality cohort characteristics
Mortality Cohort Cuba Dominican
Republic
Mexico Peru Puerto Rico Venezuela Total
Baseline sample (alive at baseline) 2813 2011 2003 1933 2009 1965 12,734
Vital status determined (% of baseline) 2635
(93.7%)
1706 (84.8%) 1844
(92.1%)
1752
(90.6%)
1563
(77.8%)
1697
(86.4%)
11,197
(87.9%)
Interviewed (% of baseline sample) 2007
(71.3%)
1197 (59.5%) 1459
(72.8%)
1311
(67.8%)
1265
(63.0%)
1257
(64.0%)
8496 (66.7%)
Deaths (% of those with vital status
determined)
608 (23.1%) 467 (27.4%) 209 (11.3%) 152 (8.7%) 298 (19.1%) 200 (11.8%) 1934 (17.3%)
Person years of follow-up 10,844.6 7448.6 5366.7 5356.8 6474.3 7031.0 42,521.9
Mortality rate per 1000 person-years 56.1 62.7 38.9 28.4 46.0 28.4 45.5
Median years of follow-up (25th and
75th centile)
4.2 (3.5–5.0) 5.0 (3.6–5.1) 3.0 (2.9–3.1) 3.0 (2.5–3.7) 4.3 (3.7–4.7) (4.0–4.8) 3.9 (3.0–4.8)
Mean age at baseline (SD) 75.2 (7.1) 75.3 (7.5) 74.3 (6.7) 74.8 (7.4) 76.3 (7.4) 72.5 (6.9) 74.8 (7.2)
Female Sex (%) 1836
(65.3%)
1325 (65.9%) 1268
(63.3%)
1183
(61.2%)
1347
(67.0%)
1252
(63.7%)
8211 (64.5%)
None did not complete primary
education (%)
692 (24.6%) 1414 (70.3%) 1418
(70.8%)
352 (18.2%) 461 (22.9%) 601 (30.6%) 4938 (38.8%)
Median number of assets (25th–75th centile) 6.0 (5.0–6.0) 5.0 (4.0–6.0) 6.0 (4.0–6.0) 6.0 (6.0–6.0) 7.0 (6.0–7.0) 6.0 (6.0–7.0) 6.0 (5.0–7.0)
No limiting physical impairment (%) 1207
(42.9%)
599 (29.8%) 835 (41.7%) 887 (45.9%) 708 (35.2%) 748 (38.1%) 4984 (39.1%)
No stroke (%) 2605
(92.6%)
1842 (91.6%) 1871
(93.4%)
1825
(94.4%)
1841
(91.6%)
1846
(93.9%)
11,830
(92.9%)
No ICD10 depressive episode (%) 2671
(95.0%)
1733 (86.2%) 1911
(95.4%)
1830
(94.7%)
1962
(97.7%)
1858
(94.6%)
11,965
(94.0%)
No dementia (%) 2517
(89.5%)
1769 (88.0%) 1823
(91.0%)
1767
(91.4%)
1765
(87.9%)
1820
(92.6%)
11,461
(90.0%)
Q1 of healthy ageing (highest level) 660 (23.5%) 199 (9.9%) 274 (13.7%) 482 (24.9%) 347 (17.3%) 576 (29.3%) 2538 (19.9%)
Self-rated health: very good 287 (10.2%) 272 (13.5%) 392 (19.6%) 409 (21.2%) 157 (7.8%) 288 (14.7%) 1805 (14.2%)
SD standard deviation, ICD International Classification of Diseases
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also predicted more strongly mortality, compared to
self-rated health, even after sociodemographic adjust-
ment (c-statistic: 0.74 vs 0.72, p < 0.05). Finally, addition
of the healthy ageing index significantly improved the
discrimination for death in a model already adjusted for
age, sex, education and number of assets (c-statistic:
mortality: 0.74 vs 0.70, p < 0.05).
Associations between healthy ageing and incident dependence
Table 4 shows the pooled meta-analysed sub-hazard ra-
tios (sHR) for the association of healthy ageing and self-
rated health with incident dependence. Regarding
healthy ageing, the sub-hazard risk was considerably
higher for the “very low level” participants compared to
“very high level” in all models (model 1: sHR = 10.61,
95%CI = 8.38–13.43; model 2: sHR = 7.76, 95%CI = 6.04–
9.97; model 3: sHR = 5.21, 95%CI = 4.02–6.75). In
addition, participants in all other levels had increased
risk compared to “very high level” participants; strength
of association, in most of the cases, was lessened when
moving to higher levels and as we adjusted for more co-
variates. However, all associations remained significant
Table 2 Dependence cohort characteristics
Dependence Cohort Cuba Dominican
Republic
Mexico Peru Puerto Rico Venezuela Total
Baseline sample (no needs for care at baseline) 2225 1770 1807 1770 1714 1754 11,040
Follow-up tracing
Interviewed (% of baseline sample) 1679
(75.5%)
1103
(62.3%)
1352
(74.8%)
1234
(69.7%)
1174
(68.5%)
1154
(65.8%)
7696
(69.7%)
Deceased (% of baseline sample) 386 (17.3%) 345 (19.5%) 159 (8.8%) 97 (5.5%) 176 (10.3%) 139 (7.9%) 1302
(11.8%)
Refused (% of baseline sample) 12 (0.5%) 39 (2.2%) 164 (9.1%) 273 (15.4%) 5 (0.3%) 217 (12.4%) 710 (6.4%)
Lost (% of baseline sample) 148 (6.7%) 283 (16.0%) 132 (7.3%) 166 (9.4%) 359 (20.9%) 244 (13.9%) 1332
(12.1%)
Participants contribute to competing risk analysis
(% of baseline sample)
2065
(92.8%)
1448
(81.8%)
1511
(83.6%)
1331
(75.2%)
1350
(78.8%)
1293
(73.7%)
8998
(81.5%)
Incidence dependencea 271 (13.1%) 376 (26.0%) 209 (13.8%) 156 (11.7%) 276 (20.4%) 238 (18.4%) 1526
(17.0%)
Competing risk (dependence free death) 78 (3.8%) 202 (14.0%) 66 (4.4%) 55 (4.1%) 116 (8.6%) 80 (6.2%) 597 (6.6%)
Person-years at risk for competing risk analysis
(divided by two for incident dependence)
8106.6 5800.9 4132.9 3928.2 5196 4944.1 32,108.7
Incidence rate per 1000 person-years 33.4 64.8 50.6 39.7 53.1 48.1 47.5
Median person-years at risk for competing risk
analysis (25th and 75th centile)
4.1 (3.2–4.9) 4.9 (2.5–5.1) 3.0 (2.8–3.1) 3.0 (2.4–3.7) 4.2 (2.9–4.6) 4.2 (3.5–4.6) 3.7 (2.7–4.6)
For those contributing in competing risk analysis
Mean age at baseline (SD) 74.4 (6.6) 74.5 (7.0) 73.9 (6.4) 74.3 (7.1) 75.2 (6.5) 71.5 (6.1) 74.0 (6.7)
Female Sex (%) 1296
(62.8%)
949 (65.5%) 957 (63.3%) 802 (60.3%) 903 (66.9%) 808 (62.5%) 5715
(63.5%)
None or did not complete primary
education (%)
479 (23.2%) 1028
(71.0%)
1051
(69.6%)
256 (19.2%) 265 (19.6%) 363 (28.1%) 3442
(38.3%)
Median number of assets (25th–75th centile) 6.0 (5.0–6.0) 5.0 (4.0–6.0) 6.0 (4.0–6.0) 6.0 (5.0–6.0) 7.0 (7.0–7.0) 6.0 (6.0–7.0) 6.0 (5.0–7.0)
No limiting physical impairment (%) 918 (44.5%) 448 (30.9%) 654 (43.3%) 614 (46.1%) 517 (38.3%) 520 (40.2%) 3671
(40.8%)
No stroke (%) 1945
(94.2%)
1347
(93.0%)
1432
(94.8%)
1279
(96.1%)
1271
(94.1%)
1231
(95.2%)
8505
(94.5%)
No ICD10 depressive episode (%) 1993
(96.5%)
1269
(87.6%)
1456
(96.4%)
1273
(95.6%)
1325
(98.1%)
1241
(96.0%)
8557
(95.1%)
No dementia (%) 1969
(95.4%)
1323
(91.4%)
1426
(94.4%)
1270
(95.4%)
1299
(96.2%)
1259
(97.4%)
8546
(95.0%)
Q1 of healthy ageing (highest level) 477 (23.1%) 148 (10.2%) 196 (13.0%) 324 (24.3%) 242 (17.9%) 409 (31.6%) 1796
(20.0%)
Self-rated health: very good 236 (11.4%) 207 (14.3%) 299 (19.8%) 284 (21.3%) 116 (8.6%) 215 (16.6%) 1357
(15.1%)
SD standard deviation, ICD International Classification of Diseases, aeither identified at follow-up interview or predicted from the informant deceased interview
Daskalopoulou et al. BMC Medical Research Methodology          (2019) 19:225 Page 6 of 11
with limited heterogeneity. Regarding self-rated health
and incident dependence, participants with low and
moderate self-rated health had increased sub-hazard risk
even in the fully-adjusted models (low: sHR = 1.70,
95%CI = 1.29–2.24; moderate: sHR = 1.29, 95%CI = 1.07–
1.55). Participants with very low self-rated health had
increased risk compared to participants of very good
self-rated health which did not remain significant once
we adjusted for more covariates. Finally, participants
with good self-rated health had no statistically different
sub-hazard risk compared to very good self-rated health
participants in all models.
Healthy ageing scores (unadjusted model) had better dis-
crimination for the incident dependence risk compared to
self-rated health (c-statistic: 0.72 vs 0.56, p < 0.05). Healthy
ageing measure was a better predictor of incident depend-
ence, compared to self-rated health, even after sociodemo-
graphic adjustment (c-statistic: 0.76 vs 0.70, p < 0.05).
Finally, addition of the healthy ageing index significantly
improved the discrimination for onset of dependence in the
Fig. 1 Kaplan-Meier failure estimates per healthy ageing level
Table 3 Meta-analysed effects of healthy ageing and self-rated health on mortality, controlling sequentially for sociodemographic
and health conditions
Hazard Ratios (HR) and 95%CI
Healthy Ageing Q1 quintile Q2 quintile Q3 quintile Q4 quintile Q5 quintile
Model 1 6.89 (5.81–8.17) 2.61 (2.16–3.14) 1.89 (1.55–2.29) 1.26 (1.02–1.56) reference
I2 = 53.4%, p = 0.057 I2 = 0.0%, p = 0.431 I2 = 0.0%, p = 0.615 I2 = 29.8%, p = 0.212
Model 2 4.23 (3.48–5.13) 2.03 (1.67–2.48) 1.60 (1.31–1.95) 1.16 (0.94–1.44) reference
I2 = 17.1%, p = 0.304 I2 = 0.0%, p = 0.585 I2 = 0.0%, p = 0.714 I2 = 22.6%, p = 0.264
Model 3 3.25 (2.63–4.02) 1.88 (1.53–2.30) 1.56 (1.27–1.91) 1.15 (0.93–1.43) reference
I2 = 28.7%, p = 0.220 I2 = 0.0%, p = 0.524 I2 = 0.0%, p = 0.726 I2 = 26.0%, p = 0.239
Self-rated health very low low moderate good very good
Model 1 4.65 (3.53–6.13) 2.36 (1.94–2.88) 1.33 (1.14–1.55) 1.06 (0.91–1.25) reference
I2 = 68.0%, p = 0.008 I2 = 73.5%, p = 0.002 I2 = 30.4%, p = 0.207 I2 = 57.0%, p = 0.040
Model 2 4.12 (3.07–5.54) 2.09 (1.71–2.57) 1.24 (1.06–1.45) 0.99 (0.85–1.17) reference
I2 = 64.6%, p = 0.015 I2 = 74.5%, p = 0.001 I2 = 61.7%, p = 0.023 I2 = 67.6%, p = 0.009
Model 3 2.78 (2.05–3.76) 1.68 (1.35–2.09) 1.16 (0.98–1.36) 0.98 (0.83–1.15) reference
I2 = 55.0%, p = 0.049 I2 = 73.9%, p = 0.002 I2 = 51.3%, p = 0.068 I2 = 69.9%, p = 0.005
HR hazard rate, CI confidence intervals, Q1: lowest level of healthy ageing; Q5: highest level of healthy ageing; Model 1: no adjustments; Model 2: adjusted for
age, sex, education level, number of assets; Model 3: Model 2 + physical impairments, stroke, depression, dementia
Daskalopoulou et al. BMC Medical Research Methodology          (2019) 19:225 Page 7 of 11
adjusted model (adjusted for age, sex, education and num-
ber of assets) (c-statistic: 0.76 vs 0.69, p < 0.05).
Population attributable fraction
We compared PAFs of healthy ageing and self-rated
health as dichotomous exposures (i.e. participants of “very
high” and “high” healthy ageing level versus all other; par-
ticipants of very good and good self-rated health versus all
other) for their contribution to mortality and onset of de-
pendence. For both outcomes, the contribution of the
dichotomised healthy ageing exposure exceeded that of
the dichotomised self-rated health exposure (Table 5).
PAFs of healthy ageing scores among countries ranged
from 32.4% (Mexico) to 52.5% (Peru) (weighted mean
43.6%) for death risk and from 51.3% (Venezuela) to
64.8% (Peru) (weighted mean 58.6%) for incident depend-
ence. PAFs of self-rated health ranged from 9.4%
(Dominican Republic) to 31.1% (Venezuela) (weighed
mean 19.3%) for mortality and from 6.7% (Puerto Rico) to
29.8% (Venezuela) (weighted mean 17.0%) for incident de-
pendence. This means that, by assuming residual free con-
founding, if we were able to have people in the two higher
levels of healthy ageing only (Q4 and Q5 quintiles) then
mortality would have been avoided by 43.6% and incident
dependence by 58.6%. Accordingly, if all participants were
of very good or good level of self-rated health, mortality
and dependence would have been avoided by 18.4 and
17.0%, respectively.
Sensitivity analysis
To test the practical usefulness of this healthy ageing
measure, we also examined if a simple sum of the 26
items, and not factor scores, could be employed without
meaningfully affect our conclusions. Cox’s models and
competing risk analyses showed similar strength and dir-
ection of associations when sum of items was used as
exposure (Additional file 1). Calculation of the relevant
Table 4 Meta-analysed effects of healthy ageing and self-rated health on incident dependence, controlling sequentially for
sociodemographic and health conditions
Incident dependence sub-HR (95% CI)
Healthy Ageing Q1 quintile Q2 quintile Q3 quintile Q4 quintile Q5 quintile
Model 1 10.61 (8.38–13.43) 4.38 (3.42–5.61) 2.85 (2.20–3.68) 1.86 (1.42–2.45) reference
I2 = 0.0%, p = 0.468 I2 = 0.0%, p = 0.696 I2 = 0.0%, p = 0.663 0.0%, p = 0.670
Model 2 7.76 (6.04–9.97) 3.63 (2.80–4.70) 2.52 (1.94–3.27) 1.72 (1.30–2.27) reference
I2 = 0.0%, p = 0.949 I2 = 0.0%, p = 0.915 I2 = 0.0%, p = 0.904 I2 = 0.0%, p = 0.830
Model 3 5.21 (4.02–6.75) 3.53 (2.71–4.59) 2.60 (2.00–3.35) 1.74 (1.32–2.29) reference
I2 = 0.0%, p = 0.735 I2 = 0.0%, p = 0.819 I2 = 0.0%, p = 0.889 I2 = 0.0%, p = 0.799
Self-rated health very low low moderate good very good
Model 1 2.18 (1.30–3.64) 2.33 (1.84–2.94) 1.54 (1.30–1.83) 1.14 (0.96–1.35) reference
I2 = 47.4%, p = 0.107 I2 = 65.1%, p = 0.014 I2 = 54.6%, p = 0.051 I2 = 24.1%, p = 0.253
Model 2 1.77 (0.99–3.18) 2.03 (1.60–2.57) 1.37 (1.15–1.62) 1.02 (0.85–1.22) reference
I2 = 1.3%, p = 0.399 I2 = 54.6%, p = 0.051 I2 = 59.2%, p = 0.031 I2 = 39.6%, p = 0.141
Model 3 1.51 (0.77–2.94) 1.70 (1.29–2.24) 1.29 (1.07–1.55) 1.01 (0.84–1.21) reference
I2 = 0.0%, p = 0.529 I2 = 0.0%, p = 0.616 I2 = 19.7%, p = 0.285 I2 = 4.1%, p = 0.390
sub-HR sub-hazard rates of competing risk analysis, CI confidence intervals, Q1: lowest level of healthy ageing; Q5: highest level of healthy ageing; Model 1: no
adjustments; Model 2: adjusted for age, sex, education level, number of assets; Model 3: Model 2 + physical impairments, stroke, depression, dementia
Table 5 Population attributable fractions (PAFs) for the
contribution of healthy ageing and self-rated health to mortality
and incident dependence
Population attributable fraction (95% CI)
Healthy ageing Self-rated health
Mortality
Cuba 44.0% (34.7–52.0%) 19.2% (11.3–26.5%)
Dominican Republic 33.6% (17.2–46.8%) 6.1% (−4.5–15.6%)
Mexico 32.4% (4.8–52.0%) 18.5% (4.6–30.4%)
Peru 52.5% (31.2–67.3%) 17.0% (−0.3–31.3%)
Puerto Rico 51.0% (34.5–63.3%) 19.8% (7.7–30.3%)
Venezuela 49.1% (33.7–60.9%) 30.0% (16.3–41.4%)
Weighted Mean 43.6% 18.4%
Incident dependence
Cuba 57.7% (44.5–67.7%) 16.8% (5.2–27.0%)
Dominican Republic 58.0% (43.8–68.6%) 7.4% (−3.6–17.3%)
Mexico 61.4% (40.4–75.0%) 18.3% (4.5–30.1%)
Peru 64.8% (44.6–77.6%) 24.6% (8.2–38.1%)
Puerto Rico 58.6% (45.8–68.4%) 6.7% (−5.2–17.3%)
Venezuela 51.3% (38.2–61.6%) 29.8% (18.1–39.9%)
Weighted Mean 58.6% 17.0%
CI Confidence Interval, Results are adjusted for age, sex, education level,
number of assets; weighted mean is calculated by considering the number of
participants in each country
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population attributable fractions also indicated overall
good prediction of mortality and onset of dependence
(but not better than the results where factor scores -and
not simple sum of the 26 items- were considered).
Discussion
In this study, we aimed to examine the predictive valid-
ity and the discrimination properties regarding mortality
and incident dependence risk of a healthy ageing index
constructed in the 10/66 cohort. We found that the
healthy ageing index, tallying with the WHO framework
of functional ability, can predict mortality and onset of
dependence in the follow-up wave, even after adjusting
for sociodemographic and health conditions. Relevant
comparative analyses indicated that this measure had
stronger associations with death risk and incident
dependence compared to a measure of self-rated health.
C-statistic also confirmed higher discrimination ability
and calculation of PAFs showed that the healthy ageing
scores provided a better overall prediction of mortality
and incident dependent risk compared to self-rated
health. Nevertheless, PAF calculations require the strong
assumptions that the study is free of bias and that re-
moving the exposure does not affect any other factors.
The practical use of this index, as a population screening
tool, was reinforced by the sensitivity analysis which
revealed that a more simplistic version, easily used by
health practitioners and care givers, can lead to similar
conclusions.
Our findings are in accordance with those from other
studies in which similar health metrics have been cre-
ated. For instance, healthy ageing metrics conceptualised
within the functional ability framework have been cre-
ated in the English Longitudinal Study of Ageing (ELSA)
[33] and the Health and Retirement Study (HRS) [34].
Both those metrics also showed good predictive ability
against mortality and other adverse health outcomes (i.e.
institutionalisation over 10 years). In addition, in com-
parison with another study in the same 10/66 popula-
tions, which examined the predictive ability of various
frailty phenotypes, this healthy ageing index showed
higher PAFs both for dependence and for mortality [20].
From our analyses, it is worth mentioning that partici-
pants in “high” or “very high” levels of healthy ageing
did not differ in the prediction of mortality when
adjusted for sociodemographic and health conditions.
However, they did differ in the incident dependence risk.
Future research could elucidate if these participants who
did not differ in their mortality risk could be charac-
terised as ‘survivors’ (living with an age-related disease
diagnosed before old age), ‘delayers’ (living with an age-
related disease diagnosed after their average life ex-
pectancy) or ‘escapers’ (living in old age without
major disease) [35]. This finding reinforces even more
the cruciality of ‘adding life to years as well as years
to life’ mantra in policy interventions [4, 36, 37].
Considering, the heterogeneity in the ageing process,
this index could potentially constitute a valuable tool
in screening and identifying those who are at higher
risk of incident dependence, but only after further
testing and abbreviation.
Among the strengths of our study is the fact that to
create this index respondents and key-informants’ data
were employed and even individuals who were unable to
provide information due to severe mental conditions or
death were included in the sample. In agreement with
the WHO report, which does not define healthy ageing
by the absence or not of a disease [4], health conditions
and diseases were not included in the conceptualisation
of it. As a result, our healthy ageing tool provides great
confidence that a broad spectrum of health was captured
and that bias towards healthier participants was limited.
In addition, our analyses were conducted on large
population-based samples in Latin American countries,
hence we were able to assess the consistency of the
observed associations across different sites within this
specific geographic area. Strength of associations did not
differ among the different countries contributing to the
generalisability of our findings. Furthermore, even
though the study design was prospective and hence
prone to attrition, modest attrition was observed which
limited any potential information bias.
Limitations include that even though catchment areas
were selected to be as representative as possible of the
wider geographical region, our findings may not be
generalisable beyond those specific areas. Cross-cultural
differences in the conceptualisation of certain questions
cannot be eliminated, even though interviewers under-
went substantial training to ensure that questionnaires
and procedures were implemented in the same way
among countries. In addition, assessments were done in
the baseline assessment and in people 65 years old and
over. As a result, this healthy ageing index was not cal-
culated in younger participants limiting the investigation
of a life-course approach [38]. Future research should
focus on the construction of this index in other longitu-
dinal studies or in harmonised datasets of various
cohorts. Building and validating indexes, which are com-
posed by the same or similar items of functional ability,
will assist in a better understanding of the ageing
process and in the identification of the different ageing
pathways that may exist.
Conclusions
The results of our study support that this healthy ageing
index, built within the functional ability framework of
WHO, can predict mortality and incident dependence
after a median of four years in subset of Latin America
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countries, part of the 10/66 population cohort. Given
the rapid increase of older people’s population and the
fact that the proportion of dependent people 60 years
old and over is expected to almost double in between
2000 and 2050 in Latin America, [23] infrastructures for
health and social care should be strengthened. An effect-
ive healthy ageing measure could be a valuable tool in
developing and targeting effective primary and secondary
prevention strategies.
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